dc.contributor.author | Hevia Urrutia, Francisco | |
dc.contributor.author | Alvarado Echeverría, Ileana | |
dc.contributor.author | Sanabria Castro, Alfredo | |
dc.contributor.author | Sánchez-Molina, Marta | |
dc.contributor.author | Meza Sierra, Luis | |
dc.contributor.author | Parajeles Vindas, Alexander | |
dc.contributor.author | Méndez Blanca, Oscar | |
dc.contributor.author | Sánchez Siles, Álvaro | |
dc.contributor.author | Saborío Rocafort, Manuel | |
dc.contributor.author | Barguil Gallardo, Marcela | |
dc.contributor.author | Chavarría Quirós, Iliana | |
dc.contributor.author | Monge Bonilla, Cecilia | |
dc.date.accessioned | 2017-02-14T18:10:28Z | |
dc.date.available | 2017-02-14T18:10:28Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | http://hdl.handle.net/20.500.11764/635 | |
dc.description | ARTICULO | es_ES |
dc.description.abstract | Wilson’s disease is an inherited disorder in which defective biliary excretion of copper leads to its accumulation, particularly in the liver and brain. Mutations in the ATP7B gene on chromosome 13 cause Wilson’s disease. If left untreated it will cause liver failure, neurological damage, and will be life threatening. It is considered a rare disease afflicting approximately 1 in 30,000 persons worldwide, although this rate is similar in the different countries some places show higher incidence rates. Since Costa Rica reports the highest number of cases per population, essential public health initiatives that promote wellbeing, prevent disease complications, and prolong life among the affected population have been carried out during the last decades. The most recent lead in this matter is the conformation of the Costa Rica’s National Alliance for Wilson’s disease whose main objective is to provide practical, operational, timely and relevant guidance to patients, families, and healthcare professionals in the region for early diagnosis and treatment. The development and implementation of the National Alliance for Wilson’s disease activities is crucial because it will reaffirm that early intervention and appropriate treatment, will reduce if not eliminate the burden of Wilson’s disease. | es_ES |
dc.description.sponsorship | Los autores | es_ES |
dc.language.iso | en | es_ES |
dc.publisher | BioMed Central | es_ES |
dc.relation.ispartofseries | Hepatology, Medicine and Policy;(2017) 2:5 | |
dc.subject | DEGENERACION HEPATOLENTICULAR | es_ES |
dc.subject | ENFERMEDAD DE WILSON | es_ES |
dc.subject | POLITICA DE SALUD | es_ES |
dc.subject | COSTA RICA | es_ES |
dc.title | National alliance for Wilson’s disease: health policy in Costa Rica | es_ES |
dc.type | Article | es_ES |